Anti-inflammatory effects of a chinese herbal medicine in atherosclerosis via estrogen receptor β mediating nitric oxide production and NF-kB suppression in endothelial cells

Cell Death and Disease

Volumn 4, Issue 3, 2013, Pages

  Wang, L ^a   Qiu, X M ^a   Hao, Q ^a   Li, D J ^a,b  

^a FUDAN UNIVERSITY   (China)

^b HAINAN MEDICAL UNIVERSITY   (China)

Author keywords

Atherosclerosis; Estrogen receptor; Inflammation; Nitric oxide; Traditional Chinese medicinal formula

Indexed keywords

ANTIINFLAMMATORY AGENT; BU SHEN NING XIN DECOCTION; CHEMOKINE RECEPTOR CCR2; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; ESTROGEN RECEPTOR BETA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERCELLULAR ADHESION MOLECULE 1; LYMPHOCYTE FUNCTION ASSOCIATED ANTIGEN 1; MALONALDEHYDE; MONOCYTE CHEMOTACTIC PROTEIN 1; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; OXIDIZED LOW DENSITY LIPOPROTEIN; UNCLASSIFIED DRUG; VASCULAR CELL ADHESION MOLECULE 1; VERY LATE ACTIVATION ANTIGEN 4; CCL2 PROTEIN, HUMAN; CUL5 PROTEIN, HUMAN; CULLIN; ENDOTHELIAL NITRIC OXIDE SYNTHASE; HERBACEOUS AGENT; NONSTEROID ANTIINFLAMMATORY AGENT; NOS3 PROTEIN, HUMAN;

ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; APOPTOSIS; ARTICLE; ATHEROSCLEROSIS; CONTROLLED STUDY; DOWN REGULATION; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; LEUKOCYTE ADHERENCE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RABBIT; UMBILICAL VEIN ENDOTHELIAL CELL; ANIMAL; CELL ADHESION; CYTOLOGY; DRUG ANTAGONISM; DRUG EFFECT; DRUG POTENTIATION; FEMALE; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; MONOCYTE; PATHOLOGY; SIGNAL TRANSDUCTION;

ORYCTOLAGUS CUNICULUS;

ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; APOPTOSIS; ATHEROSCLEROSIS; CELL ADHESION; CHEMOKINE CCL2; CULLIN PROTEINS; DRUGS, CHINESE HERBAL; E-SELECTIN; ESTROGEN RECEPTOR BETA; FEMALE; GENE EXPRESSION REGULATION; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; INTERCELLULAR ADHESION MOLECULE-1; MONOCYTES; NF-KAPPA B; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE III; RABBITS; SIGNAL TRANSDUCTION;

EID: 84875909773     PISSN: None     EISSN: 20414889     Source Type: Journal    
DOI: 10.1038/cddis.2013.66     Document Type: Article

References (52)

1. Tousoulis D, Kampoli AM, Papageorgiou N, Androulakis E, Antoniades C, Toutouzas K et al. Pathophysiology of atherosclerosis: the role of inflammation. Curr Pharm Des 2011; 17: 4089-4110.
2. Libby P. Inflammation in atherosclerosis. Nature 2002; 420: 868-874.
3. Van der Heiden K, Cuhlmann S, Luong le A, Zakkar M, Evans PC. Role of nuclear factor kappaB in cardiovascular health and disease. Clin Sci (Lond) 2010; 118: 593-605.
4. Ignarro LJ, Napoli C. Novel features of nitric oxide, endothelial nitric oxide synthase, and atherosclerosis. Curr Atheroscler Rep 2004; 6: 281-287.
5. Ignarro LJ, Buga GM, Wei LH, Bauer PM, Wu G, del Soldato P. Role of the arginine-nitric oxide pathway in the regulation of vascular smooth muscle cell proliferation. Proc Natl Acad Sci USA 2001; 98: 4202-4208.
6. Demer L, Tintut Y. The roles of lipid oxidation products and receptor activator of nuclear factor-kappaB signaling in atherosclerotic calcification. Circ Res 2011; 108: 1482-1493.
7. Mendelsohn ME. Protective effects of estrogen on the cardiovascular system. Am J Cardiol 2002; 89: 12E-17E; discussion 17E-18E.
8. Meyer MR, Haas E, Barton M. Gender differences of cardiovascular disease: new perspectives for estrogen receptor signaling. Hypertension 2006; 47: 1019-1026.
9. Osako MK, Nakagami H, Koibuchi N, Shimizu H, Nakagami F, Koriyama H et al. Estrogen inhibits vascular calcification via vascular RANKL system: common mechanism of osteoporosis and vascular calcification. Circ Res 2010; 107: 466-475.
10. Mendelsohn ME, Karas RH. The protective effects of estrogen on the cardiovascular system. N Engl J Med 1999; 340: 1801-1811.
11. Hodgin JB, Maeda N. Minireview: estrogen and mouse models of atherosclerosis. Endocrinology 2002; 143: 4495-4501.
12. Christian RC, Liu PY, Harrington S, Ruan M, Miller VM, Fitzpatrick LA. Intimal estrogen receptor (ER)beta, but not ERalpha expression, is correlated with coronary calcification and atherosclerosis in pre- and postmenopausal women. J Clin Endocrinol Metab 2006; 91: 2713-2720.
13. Rexrode KM, Ridker PM, Hegener HH, Buring JE, Manson JE, Zee RY. Polymorphisms and haplotypes of the estrogen receptor-beta gene (ESR2) and cardiovascular disease in men and women. Clin Chem 2007; 53: 1749-1756.
14. Hodges YK, Tung L, Yan XD, Graham JD, Horwitz KB, Horwitz LD. Estrogen receptors alpha and beta: prevalence of estrogen receptor beta mRNA in human vascular smooth muscle and transcriptional effects. Circulation 2000; 101: 1792-1798.
15. Liu PY, Christian RC, Ruan M, Miller VM, Fitzpatrick LA. Correlating androgen and estrogen steroid receptor expression with coronary calcification and atherosclerosis in men without known coronary artery disease. J Clin Endocrinol Metab 2005; 90: 1041-1046.
16. Efferth T, Li PC, Konkimalla VS, Kaina B. From traditional Chinese medicine to rational cancer therapy. Trends Mol Med 2007; 13: 353-361.
17. Wang L, Zhou GB, Liu P, Song JH, Liang Y, Yan XJ et al. Dissection of mechanisms of Chinese medicinal formula Realgar-Indigo naturalis as an effective treatment for promyelocytic leukemia. Proc Natl Acad Sci USA 2008; 105: 4826-4831.
18. Chow MS, Huang Y. Utilizing Chinese medicines to improve cancer therapy - fiction or realityCurr Drug Discov Technol 2010; 7: 1.
19. Park WH, Hong MY, Chung KH, Kim HM, Lee YC, Kim CH. Effects of traditional herbal medicine, Hwaotang, on atherosclerosis using the spontaneous familial hypercholesterolemia model, Kurosawa and Kusanagi-hypercholesterolemic rabbits and the venous thrombosis rats. Phytother Res 2005; 19: 846-853.
20. Sieveking DP, Woo KS, Fung KP, Lundman P, Nakhla S, Celermajer DS. Chinese herbs Danshen and Gegen modulate key early atherogenic events in vitro. Int J Cardiol 2005; 105: 40-45.
21. Lee S, Lim HJ, Park HY, Lee KS, Park JH, Jang Y. Berberine inhibits rat vascular smooth muscle cell proliferation and migration in vitro and improves neointima formation after balloon injury in vivo. Berberine improves neointima formation in a rat model. Atherosclerosis 2006; 186: 29-37.
22. Wang L, Hao Q, Wang YD, Wang WJ, Li DJ. Protective effects of dehydroepiandrosterone on atherosclerosis in ovariectomized rabbits via alleviating inflammatory injury in endothelial cells. Atherosclerosis 2011; 214: 47-57.
23. Jackson KC, Wohlers LM, Lovering RM, Schuh RA, Maher AC, Bonen A et al. Ectopic lipid deposition and the metabolic profile of skeletal muscle in ovariectomized mice. Am J Physiol Regul Integr Comp Physiol 2012; 304: R206-R217.
24. Chen MF, Hsu HC, Liau CS, Lee YT. The role of vitamin E on the anti-atherosclerotic effect of fish oil in diet-induced hypercholesterolemic rabbits. Prostaglandins Other Lipid Mediat 1999; 57: 99-111.
25. Freyschuss A, Al-Schurbaji A, Bjorkhem I, Babiker A, Diczfalusy U, Berglund L et al. On the anti-atherogenic effect of the antioxidant BHT in cholesterol-fed rabbits: inverse relation between serum triglycerides and atheromatous lesions. Biochim Biophys Acta 2001; 1534: 129-138.
26. Holm P, Andersen HL, Andersen MR, Erhardtsen E, Stender S. The direct antiatherogenic effect of estrogen is present, absent, or reversed, depending on the state of the arterial endothelium. A time course study in cholesterol-clamped rabbits. Circulation 1999; 100: 1727-1733.
27. Chen F, Knecht K, Birzin E, Fisher J, Wilkinson H, Mojena M et al. Direct agonist/antagonist functions of dehydroepiandrosterone. Endocrinology 2005; 146: 4568-4576.
28. Hodis HN, Mack WJ, Azen SP, Lobo RA, Shoupe D, Mahrer PR et al. Hormone therapy and the progression of coronary-artery atherosclerosis in postmenopausal women. N Engl J Med 2003; 349: 535-545.
29. Hodis HN, Collins P, Mack WJ, Schierbeck LL. The timing hypothesis for coronary heart disease prevention with hormone therapy: past, present and future in perspective. Climacteric 2012; 15: 217-228.
30. Whayne TF Jr.. Atherosclerosis: current status of prevention and treatment. Int J Angiol 2011; 20: 213-222.
31. Hayashi T, Matsui-Hirai H, Miyazaki-Akita A, Fukatsu A, Funami J, Ding QF et al. Endothelial cellular senescence is inhibited by nitric oxide: implications in atherosclerosis associated with menopause and diabetes. Proc Natl Acad Sci USA 2006; 103: 17018-17023.
32. Scalera F, Martens-Lobenhoffer J, Tager M, Bukowska A, Lendeckel U, Bode-Boger SM. Effect of L-arginine on asymmetric dimethylarginine (ADMA) or homocysteine-accelerated endothelial cell aging. Biochem Biophys Res Commun 2006; 345: 1075-1082.
33. Arnal JF, Gourdy P, Elhage R, Garmy-Susini B, Delmas E, Brouchet L et al. Estrogens and atherosclerosis. Eur J Endocrinol 2004; 150: 113-117.
34. Su S, Guo J, Duan JA, Wang T, Qian D, Shang E et al. Ultra-performance liquid chromatography-tandem mass spectrometry analysis of the bioactive components and their metabolites of Shaofu Zhuyu decoction active extract in rat plasma. J Chromatogr B Analyt Technol Biomed Life Sci 2010; 878: 355-362.
35. Dong W, Wang P, Meng X, Sun H, Zhang A, Wang W et al. Ultra-performance liquid chromatography-high-definition mass spectrometry analysis of constituents in the root of Radix Stemonae and those absorbed in blood after oral administration of the extract of the crude drug. Phytochem Anal 2012; 23: 657-667.
36. Bjorkbacka H, Fredrikson GN, Nilsson J. Emerging biomarkers and intervention targets for immune-modulation of atherosclerosis - A review of the experimental evidence. Atherosclerosis 2012; 227: 9-17.
37. Van-Assche T, Huygelen V, Crabtree MJ, Antoniades C. Gene therapy targeting inflammation in atherosclerosis. Curr Pharm Des 2011; 17: 4210-4223.
38. Hodgin JB, Krege JH, Reddick RL, Korach KS, Smithies O, Maeda N. Estrogen receptor alpha is a major mediator of 17beta-estradiol's atheroprotective effects on lesion size in Apoe-/- mice. J Clin Invest 2001; 107: 333-340.
39. Register TC. Primate models in women's health: inflammation and atherogenesis in female cynomolgus macaques (Macaca fascicularis). Am J Primatol 2009; 71: 766-775.
40. Dornas WC, Oliveira TT, Augusto LE, Nagem TJ. Experimental atherosclerosis in rabbits. Arq Bras Cardiol 2010; 95: 272-278.
41. Sun J (eds). Methodology of Animal Experiments. People's Health Publishing House: Beijing 356-357, p, 2001.
42. Blumel JE, Castelo-Branco C, Gonzalez P, Moyano C, Iturriaga M, Videla L et al. Transdermal estrogens do not appear to modify the extent of lesional areas of aortic atherosclerosis in oophorectomized rabbits on a cholesterol-rich diet. Atherosclerosis 2000; 148: 303-308.
43. Ducasse E, Chevalier J, Cosset JM, Creusy C, Eschwege F, Speziale F et al. Ionizing radiation to prevent arterial intimal hyperplasia at the edges of the stent: induces necrosis and fibrosis. J Surg Res 2006; 135: 331-336.
44. Liu XD, Chen HB, Tong Q, Li XY, Zhu MJ, Wu ZF et al. Molecular characterization of caveolin-1 in pigs infected with Haemophilus parasuis. J Immunol 2011; 186: 3031-3046.
45. Huang FY,MeiWL, Li YN, Tan GH, Dai HF,Guo JL et al. Toxicarioside A inhibits tumor growth and angiogenesis: involvement of TGF-beta/Endoglin signaling. PLoS One 2012; 7: e50351.
46. ZhongW, Zou G, Gu J, Zhang J. L-arginine attenuates high glucose-accelerated senescence in human umbilical vein endothelial cells. Diabetes Res Clin Pract 2010; 89: 38-45.
47. Chen YJ, Lee MT, Yao HC, Hsiao PW, Ke FC, Hwang JJ. Crucial role of estrogen receptoralpha interaction with transcription coregulators in follicle-stimulating hormone and transforming growth factor beta1 up-regulation of steroidogenesis in rat ovarian granulosa cells. Endocrinology 2008; 149: 4658-4668.
48. Somponpun S, Sladek CD. Role of estrogen receptor-beta in regulation of vasopressin and oxytocin release in vitro. Endocrinology 2002; 143: 2899-2904.
49. Yu X, Ling W, Mi M. Relationship of impairment induced by intracellular S-adenosylhomocysteine accumulation with DNA methylation in human umbilical vein endothelial cells treated with 3-deazaadenosine. Int J Exp Pathol 2009; 90: 638-648.
50. Wang L, Wang YD, Wang WJ, Li DJ. Differential regulation of dehydroepiandrosterone and estrogen on bone and uterus in ovariectomized mice. Osteoporos Int 2009; 20: 79-92.
51. Toth B, Saadat G, Geller A, Scholz C, Schulze S, Friese K et al. Human umbilical vascular endothelial cells express estrogen receptor beta (ERbeta) and progesterone receptor A (PR-A), but not ERalpha and PR-B. Histochem Cell Biol 2008; 130: 399-405.
52. Sahara M, Sata M, Morita T, Hirata Y, Nagai R. Nicorandil attenuates monocrotalineinduced vascular endothelial damage and pulmonary arterial hypertension. PLoS One 2012; 7: e33367.